Mapping BusinessOne market access insights with Veeva OpenData reduces the payer challenges that physicians face on a day-to-day basis and helps deliver better patient outcomes because treatment can be initiated more quickly.
Through testing facilities across Asia, the UK and the US, our Global Market Access team delivers a local service in the local language on a worldwide basis.
Covance Market Access and Phase IV Solutions has the experience and forward thinking to help you optimize the clinical and commercial value of your brand.
By evaluating payers, providers, and patients, we can generate real-world,value-based evidence that helps you determine pricing and set your market access strategies.
We have entered into a strategic partnership agreement with Lenovo Data Intelligence Business Group to work together in areas such as technology, products,business and market access.
Not considering your market access strategy by the time you design your Phase III trials Much of the evidence that will be examined by payers will be clinical trial data, so it is critical that you set these trials up with the payer drivers in mind to ensure that the criteria they are looking for is clear in your clinical trial data.
コーヴァンスマーケットアクセス。
Covance Market Access.
当社マーケットアクセスコンサルティング。
Our Market Access Consulting.
しマーケットアクセス市販化チーム。
Market Access and Commercialization Team.
コーヴァンスのマーケットアクセス-アジア太平洋。
Covance Market Access- Asia-Pacific.
医療経済およびマーケットアクセスに関するトレーニング。
Health economic and market access training.
総合的なマーケットアクセス戦略を構築。
Build a comprehensive market access strategy.
コーヴァンスマーケットアクセス患者サポートフィールドサービス安全。
Covance Market Access Patient Support Field Services Drug Safety.
日本語
中文
عربى
Български
বাংলা
Český
Dansk
Deutsch
Ελληνικά
Español
Suomi
Français
עִברִית
हिंदी
Hrvatski
Magyar
Bahasa indonesia
Italiano
Қазақ
한국어
മലയാളം
मराठी
Bahasa malay
Nederlands
Norsk
Polski
Português
Română
Русский
Slovenský
Slovenski
Српски
Svenska
தமிழ்
తెలుగు
ไทย
Tagalog
Turkce
Українська
اردو
Tiếng việt